Citius Oncology Inc. (CTOR)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
1.21
0.01 (0.83%)
At close: Jan 30, 2025, 11:35 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY24 | FY23 | FY22 | FY21 |
Revenue | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a |
Operating Income | -20.57M | -12.12M | -4.86M | n/a |
Interest Income | n/a | n/a | n/a | n/a |
Pretax Income | -20.57M | -12.12M | -4.86M | -10.11K |
Net Income | -21.15M | -12.70M | -5.43M | -10.11K |
Selling & General & Admin | 15.65M | 7.88M | 1.43M | n/a |
Research & Development | 4.93M | 4.24M | 3.43M | n/a |
Other Expenses | n/a | n/a | n/a | n/a |
Operating Expenses | 20.57M | 12.12M | 4.86M | n/a |
Interest Expense | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 20.57M | 12.12M | 4.86M | n/a |
Income Tax | 576.00K | 576.00K | 576.00K | n/a |
Shares Outstanding (Basic) | n/a | n/a | 9.02M | 8.14M |
Shares Outstanding (Diluted) | n/a | n/a | 9.02M | 8.14M |
EPS (Basic) | n/a | n/a | 0.04 | -0.00 |
EPS (Diluted) | n/a | n/a | 0.04 | -0.00 |
EBITDA | -20.57M | -12.12M | -4.86M | -10.11K |
Depreciation & Amortization | n/a | n/a | n/a | n/a |